Breaking News, Financial News

Financial Report: Abbott 3Q08

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Abbott 3Q Revenues: $7.5 billion (+18%) 3Q Earnings: $1.1 billion (+51%) YTD Revenues: $22.0 billion (+15%) YTD Earnings: $3.3 billion (+39%) Comments: Worldwide pharmaceutical sales were $4.1 billion in the quarter (+17%), driven by growth in Humira, Kaletra, TriCor, and Niaspan. U.S. sales were $3.7 billion (+18%). International sales were $2.0 billion (+22%) with a positive impact of exchange of 10%. Humira sales reached $1.2 billion in the quarter (+50%). Kaletra sales were $3...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters